Xiaoxiong Liu

发表

Dickkopf-3 protects against cardiac dysfunction and ventricular remodelling following myocardial infarction

Hongliang Li, Liangpeng Li, Xue-Hai Zhu, 2015, Basic Research in Cardiology.

Cardioprotective role of growth/differentiation factor 1 in post‐infarction left ventricular remodelling and dysfunction

Hongliang Li, Liangpeng Li, Xue-Hai Zhu, 2015, The Journal of pathology.

Toll‐interacting protein contributes to mortality following myocardial infarction through promoting inflammation and apoptosis

Hongliang Li, Xue-Hai Zhu, Xiao-Jing Zhang, 2015, British journal of pharmacology.

SH2B1 is critical for the regulation of cardiac remodelling in response to pressure overload.

He Huang, Congxin Huang, Yanhong Tang, 2015, Cardiovascular research.

Serum metabolomic abnormalities in survivors of non-severe COVID-19

Xiaoxiong Liu, Ang Guo, Qian Luo, 2022, Heliyon.

Carboxyl‐Terminal Modulator Protein Ameliorates Pathological Cardiac Hypertrophy by Suppressing the Protein Kinase B Signaling Pathway

Jia Liu, Zhi‐Gang She, Shuyan Li, 2018, Journal of the American Heart Association.

Physalin B inhibits PDGF-BB-induced VSMC proliferation, migration and phenotypic transformation by activating the Nrf2 pathway.

Changjiang Zhang, H. Xia, Xutao Zhang, 2021, Food & function.

Novel Role for Caspase-Activated DNase in the Regulation of Pathological Cardiac Hypertrophy

Kai Huang, Lu Gao, Hongliang Li, 2015, Hypertension.

Interferon regulatory factor 9 is an essential mediator of heart dysfunction and cell death following myocardial ischemia/reperfusion injury

Hongliang Li, Zhi‐Gang She, Xue-Hai Zhu, 2014, Basic Research in Cardiology.

Downregulation of P300/CBP-Associated Factor Protects from Vascular Aging via Nrf2 Signal Pathway Activation

Xiaoxiong Liu, Changwu Xu, Hao Xia, 2022, International journal of molecular sciences.

Decreased Counts of T Lymphocyte Subsets Predict Prognosis in SARS-CoV-2-Infected Pneumonia in Wuhan, China: a Retrospective Study

Zuxin Chen, Xin-An Liu, Wanli Jiang, 2020, SSRN Electronic Journal.

Loss of Junctional Adhesion Molecule A Promotes Severe Steatohepatitis in Mice on a Diet High in Saturated Fat, Fructose, and Cholesterol.

F. Anania, Hongliang Li, C. Desai, 2016, Gastroenterology.

Interferon Regulatory Factor 1 Is Required for Cardiac Remodeling in Response to Pressure Overload

Hongliang Li, Liangpeng Li, Ling Huang, 2014, Hypertension.

Novel Role for Pleckstrin Homology‐Like Domain Family A, Member 3 in the Regulation of Pathological Cardiac Hypertrophy

Fan Wang, Jia Liu, Shuyan Li, 2019, Journal of the American Heart Association.

Vinexin-β exacerbates cardiac dysfunction post-myocardial infarction via mediating apoptotic and inflammatory responses.

Hongliang Li, Xue-Hai Zhu, Xiao-Jing Zhang, 2015, Clinical science.

ALK7 protects against pathological cardiac hypertrophy in mice.

He Huang, Congxin Huang, Yanhong Tang, 2015, Cardiovascular research.

Downregulation of p300/CBP‐associated factor inhibits cardiomyocyte apoptosis via suppression of NF‐κB pathway in ischaemia/reperfusion injury rats

H. Xia, Xiaoxiong Liu, Changwu Xu, 2021, Journal of cellular and molecular medicine.

Galangin delivered by retinoic acid-modified nanoparticles targeted hepatic stellate cells for the treatment of hepatic fibrosis

H. Xia, Hanlin Xu, Xiaoxiong Liu, 2023, RSC advances.

Clinical characteristics, risk factors, and cardiac manifestations of cancer patients with COVID-19

Zhenhong Hu, Hong Jiang, Yanwen Wu, 2021, Journal of applied physiology.

Galangin inhibits neointima formation induced by vascular injury via regulating the PI3K/AKT/mTOR pathway.

Ming Li, H. Xia, Xiaoxiong Liu, 2022, Food & function.

Novel Role for Caspase-Activated DNase in the Regulation of Pathological Cardiac Hypertrophy

Lu Gao, Hongliang Li, D. Jiang, 2015, Hypertension.